8 results on '"Maiga M"'
Search Results
2. Whole Genome Sequencing of Mycobacterium africanum Strains from Mali Provides Insights into the Mechanisms of Geographic Restriction
- Author
-
Winglee, K. (author), McGuire, A.M. (author), Maiga, M. (author), Abeel, T.E.P.M.F. (author), Shea, T. (author), Desjardins, C.A. (author), Diarra, B. (author), Baya, B. (author), Sanogo, M. (author), Diallo, S. (author), Earl, A. (author), Bishai, W.R. (author), Winglee, K. (author), McGuire, A.M. (author), Maiga, M. (author), Abeel, T.E.P.M.F. (author), Shea, T. (author), Desjardins, C.A. (author), Diarra, B. (author), Baya, B. (author), Sanogo, M. (author), Diallo, S. (author), Earl, A. (author), and Bishai, W.R. (author)
- Abstract
Background Mycobacterium africanum, made up of lineages 5 and 6 within the Mycobacterium tuberculosis complex (MTC), causes up to half of all tuberculosis cases in West Africa, but is rarely found outside of this region. The reasons for this geographical restriction remain unknown. Possible reasons include a geographically restricted animal reservoir, a unique preference for hosts of West African ethnicity, and an inability to compete with other lineages outside of West Africa. These latter two hypotheses could be caused by loss of fitness or altered interactions with the host immune system. Methodology/Principal Findings We sequenced 92 MTC clinical isolates from Mali, including two lineage 5 and 24 lineage 6 strains. Our genome sequencing assembly, alignment, phylogeny and average nucleotide identity analyses enabled us to identify features that typify lineages 5 and 6 and made clear that these lineages do not constitute a distinct species within the MTC. We found that in Mali, lineage 6 and lineage 4 strains have similar levels of diversity and evolve drug resistance through similar mechanisms. In the process, we identified a putative novel streptomycin resistance mutation. In addition, we found evidence of person-to-person transmission of lineage 6 isolates and showed that lineage 6 is not enriched for mutations in virulence-associated genes. Conclusions This is the largest collection of lineage 5 and 6 whole genome sequences to date, and our assembly and alignment data provide valuable insights into what distinguishes these lineages from other MTC lineages. Lineages 5 and 6 do not appear to be geographically restricted due to an inability to transmit between West African hosts or to an elevated number of mutations in virulence-associated genes. However, lineage-specific mutations, such as mutations in cell wall structure, secretion systems and cofactor biosynthesis, provide alternative mechanisms that may lead to host specificity., Intelligent Systems, Electrical Engineering, Mathematics and Computer Science
- Published
- 2016
3. Nontuberculous Mycobacteria Isolated from Tuberculosis Suspects in Ibadan, Nigeria.
- Author
-
Cadmus, S.I., Diarra, B., Traore, B., Maiga, M., Siddiqui, S., Tounkara, A., Falodun, O., Lawal, W., Adewole, I.F., Murphy, R., Soolingen, D. van, Taiwo, B., Cadmus, S.I., Diarra, B., Traore, B., Maiga, M., Siddiqui, S., Tounkara, A., Falodun, O., Lawal, W., Adewole, I.F., Murphy, R., Soolingen, D. van, and Taiwo, B.
- Abstract
Contains fulltext : 171065.pdf (publisher's version ) (Open Access)
- Published
- 2016
4. Nontuberculous Mycobacteria Isolated from Tuberculosis Suspects in Ibadan, Nigeria.
- Author
-
Cadmus, S.I., Diarra, B., Traore, B., Maiga, M., Siddiqui, S., Tounkara, A., Falodun, O., Lawal, W., Adewole, I.F., Murphy, R., Soolingen, D. van, Taiwo, B., Cadmus, S.I., Diarra, B., Traore, B., Maiga, M., Siddiqui, S., Tounkara, A., Falodun, O., Lawal, W., Adewole, I.F., Murphy, R., Soolingen, D. van, and Taiwo, B.
- Abstract
Contains fulltext : 171065.pdf (publisher's version ) (Open Access)
- Published
- 2016
5. APOBEC3G variants and protection against HIV-1 infection in Burkina Faso
- Author
-
Compaore, TR, Soubeiga, ST, Ouattara, AK, Obiri-Yeboah, D, Tchelougou, D, Maiga, M, Assih, M, Bisseye, C, Bakouan, D, Compaore, IP, Dembele, A, Martinson, J, Simpore, J, Compaore, TR, Soubeiga, ST, Ouattara, AK, Obiri-Yeboah, D, Tchelougou, D, Maiga, M, Assih, M, Bisseye, C, Bakouan, D, Compaore, IP, Dembele, A, Martinson, J, and Simpore, J
- Abstract
Studies on host factors, particularly the APOBEC3G gene, have previously found an association with AIDS progression in some populations and against some HIV-1 strains but not others. Our study had two main objectives: firstly, to screen a population from Burkina Faso for three variants of APOBEC3G previously described, and secondly to analyze the effect of these three variants and their haplotypes on HIV-1 infection with Circulating Recombinant Forms (CRFs) present in Burkina Faso. This case control study involved 708 seropositive and seronegative individuals. Genotyping was done by the TaqMan allelic discrimination method. Minor allele frequencies of rs6001417 (p<0.05), rs8177832 (P<0.05), and rs35228531 (P<0.001) were higher in seronegative subjects. The rs6001417 and rs8177832 SNPs were associated with HIV-1 infection in an additive model (P<0.01). Furthermore the SNP rs35228531 was also associated with HIV-1 infection in a dominant model (P<0.001). Odds ratio analysis of genotypes and alleles of the different APOBEC3G variants showed that there is a strong association between the minor genetic variants, genotype of the three SNPs, and HIV-1 status. Haplotype analysis demonstrated that rs6001417, rs8177832, and rs35228531 are in linkage disequilibrium. The haplotype GGT from the rs6001417, rs8177832 and rs35228531 respectively has a protective effect OR = 0.54 [0.43-0.68] with P<0.001. There was also associations between the haplotypes GGC OR = 1.6 [1.1;-2.3] P<0.05, and CGC OR = 5.21 [2.4-11.3] P<0.001, which increase the risk of infection by HIV-1 from almost two (2) to five (5) fold. This study demonstrates an association of rs6001417, rs8177832, and rs35228531 of APOBEC3G with HIV-1 infection in a population from Burkina Faso.
- Published
- 2016
6. APOBEC3G variants and protection against HIV-1 infection in Burkina Faso
- Author
-
Compaore, TR, Soubeiga, ST, Ouattara, AK, Obiri-Yeboah, D, Tchelougou, D, Maiga, M, Assih, M, Bisseye, C, Bakouan, D, Compaore, IP, Dembele, A, Martinson, J, Simpore, J, Compaore, TR, Soubeiga, ST, Ouattara, AK, Obiri-Yeboah, D, Tchelougou, D, Maiga, M, Assih, M, Bisseye, C, Bakouan, D, Compaore, IP, Dembele, A, Martinson, J, and Simpore, J
- Abstract
Studies on host factors, particularly the APOBEC3G gene, have previously found an association with AIDS progression in some populations and against some HIV-1 strains but not others. Our study had two main objectives: firstly, to screen a population from Burkina Faso for three variants of APOBEC3G previously described, and secondly to analyze the effect of these three variants and their haplotypes on HIV-1 infection with Circulating Recombinant Forms (CRFs) present in Burkina Faso. This case control study involved 708 seropositive and seronegative individuals. Genotyping was done by the TaqMan allelic discrimination method. Minor allele frequencies of rs6001417 (p<0.05), rs8177832 (P<0.05), and rs35228531 (P<0.001) were higher in seronegative subjects. The rs6001417 and rs8177832 SNPs were associated with HIV-1 infection in an additive model (P<0.01). Furthermore the SNP rs35228531 was also associated with HIV-1 infection in a dominant model (P<0.001). Odds ratio analysis of genotypes and alleles of the different APOBEC3G variants showed that there is a strong association between the minor genetic variants, genotype of the three SNPs, and HIV-1 status. Haplotype analysis demonstrated that rs6001417, rs8177832, and rs35228531 are in linkage disequilibrium. The haplotype GGT from the rs6001417, rs8177832 and rs35228531 respectively has a protective effect OR = 0.54 [0.43-0.68] with P<0.001. There was also associations between the haplotypes GGC OR = 1.6 [1.1;-2.3] P<0.05, and CGC OR = 5.21 [2.4-11.3] P<0.001, which increase the risk of infection by HIV-1 from almost two (2) to five (5) fold. This study demonstrates an association of rs6001417, rs8177832, and rs35228531 of APOBEC3G with HIV-1 infection in a population from Burkina Faso.
- Published
- 2016
7. Whole Genome Sequencing of Mycobacterium africanum Strains from Mali Provides Insights into the Mechanisms of Geographic Restriction
- Author
-
Winglee, K. (author), McGuire, A.M. (author), Maiga, M. (author), Abeel, T.E.P.M.F. (author), Shea, T. (author), Desjardins, C.A. (author), Diarra, B. (author), Baya, B. (author), Sanogo, M. (author), Diallo, S. (author), Earl, A. (author), Bishai, W.R. (author), Winglee, K. (author), McGuire, A.M. (author), Maiga, M. (author), Abeel, T.E.P.M.F. (author), Shea, T. (author), Desjardins, C.A. (author), Diarra, B. (author), Baya, B. (author), Sanogo, M. (author), Diallo, S. (author), Earl, A. (author), and Bishai, W.R. (author)
- Abstract
Background Mycobacterium africanum, made up of lineages 5 and 6 within the Mycobacterium tuberculosis complex (MTC), causes up to half of all tuberculosis cases in West Africa, but is rarely found outside of this region. The reasons for this geographical restriction remain unknown. Possible reasons include a geographically restricted animal reservoir, a unique preference for hosts of West African ethnicity, and an inability to compete with other lineages outside of West Africa. These latter two hypotheses could be caused by loss of fitness or altered interactions with the host immune system. Methodology/Principal Findings We sequenced 92 MTC clinical isolates from Mali, including two lineage 5 and 24 lineage 6 strains. Our genome sequencing assembly, alignment, phylogeny and average nucleotide identity analyses enabled us to identify features that typify lineages 5 and 6 and made clear that these lineages do not constitute a distinct species within the MTC. We found that in Mali, lineage 6 and lineage 4 strains have similar levels of diversity and evolve drug resistance through similar mechanisms. In the process, we identified a putative novel streptomycin resistance mutation. In addition, we found evidence of person-to-person transmission of lineage 6 isolates and showed that lineage 6 is not enriched for mutations in virulence-associated genes. Conclusions This is the largest collection of lineage 5 and 6 whole genome sequences to date, and our assembly and alignment data provide valuable insights into what distinguishes these lineages from other MTC lineages. Lineages 5 and 6 do not appear to be geographically restricted due to an inability to transmit between West African hosts or to an elevated number of mutations in virulence-associated genes. However, lineage-specific mutations, such as mutations in cell wall structure, secretion systems and cofactor biosynthesis, provide alternative mechanisms that may lead to host specificity., Intelligent Systems, Electrical Engineering, Mathematics and Computer Science
- Published
- 2016
8. Reporter phage and breath tests: Emerging phenotypic assays for diagnosing active tuberculosis, antibiotic resistance, and treatment efficacy
- Author
-
Jain, P, Thaler, DS, Maiga, M, Timmins, GS, Bishai, WR, Hatfull, GF, Larsen, MH, Jacobs, WR, Jain, P, Thaler, DS, Maiga, M, Timmins, GS, Bishai, WR, Hatfull, GF, Larsen, MH, and Jacobs, WR
- Abstract
The rapid and accurate diagnosis of active tuberculosis (TB) and its drug susceptibility remain a challenge. Phenotypic assays allow determination of antibiotic susceptibilities even if sequence data are not available or informative. We review 2 emerging diagnostic approaches, reporter phage and breath tests, both of which assay mycobacterial metabolism. The reporter phage signal, Green fluorescent protein (GFP) or β-galactosidase, indicates transcription and translation inside the recipient bacilli and its attenuation by antibiotics.Different breath tests assay, (1) exhaled antigen 85, (2) mycobacterial urease activity, and (3) detection by trained rats of diseasespecific odor in sputum, have also been developed. When compared with culture, reporter phage assays shorten the time for initial diagnosis of drug susceptibility by several days. Both reporter phage and breath tests have promise as early markers to determine the efficacy of treatment. While sputum often remains smear and Mycobacterium tuberculosis DNA positive early in the course of efficacious antituberculous treatment, we predict that both breath and phage tests will rapidly become negative. If this hypothesis proves correct, phage assays and breath tests could become important surrogate markers in early bactericidal activity (EBA) studies of new antibiotics. © The Author 2011.
- Published
- 2011
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.